Proud to present the fruits of our 6-year teamwork with @SandyFeng8 @UCSFTransplant, @JoshLevitskyMD
@NMTransplant, & @timucin_taner @MayoTransplant
with support from @NIAID @NIH
@NMTransplant, & @timucin_taner @MayoTransplant
with support from @NIAID @NIH
A new phase 1 clinical trial tests a selective, immune-suppressing regulatory #TCell therapy that may reduce the need for systemic immunosuppressive drugs after #LiverTransplantation, according to work from the @SandyFeng8 lab at @UCSFSurgery. scim.ag/t0View quoted post on X
